Thesis: fraud, analyst: Ningni research, sector: financial.
see below
More ... latest change: 2026-02-28
Marex Group plc (NASDAQ: MRX): A Financial House of Cards
We are short Marex Group plc (NASDAQ: MRX), because, in our opinion, Marex has engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure. We have uncovered evidence suggesting Marex is a financial house of cards, with a balance sheet riddled with holes and financials that we believe are unreliable.
The Luxembourg Shell Game: We found that Marex used an opaque fund structure in Luxembourg to manipulate earnings and mask risk. In 2020, during preparations for its first (ultimately failed) IPO attempt, Marex bailed out a failed volatility fund (VPF) to conceal an estimated ~$27 million loss. The bailout and subsequent acquisition were not approved by the board’s acquisition committee, a significant break from governance protocols.
Hidden Off-Balance-Sheet Vehicle: Post-VPF bailout, Marex created a new undisclosed off-balance-sheet entity, the “Marex Fund.” We found evidence that Marex’s role as the fund’s sole investor was obscured through a misclassified entry in a subsidiary’s books. This new fund holds more than $930 million in derivatives, with Marex as the sole counterparty, yet is excluded from the group’s risk models. Strikingly, group auditor Deloitte resigned from its legally mandated role at this entity, leaving the fund unaudited. A material event, especially given the near billion-dollar derivative exposure, which Marex failed to disclose to investors.
A Self-Dealing Loophole to Manufacture Profit: In our opinion, Marex is exploiting revenue recognition policies to inflate trading income by selling OTC financial instruments (derivatives, structured notes, etc.) to its off-balance-sheet "Marex Fund"—an entity it secretly owns and controls. Given that Marex executives determine the "fair value" for both sides of the trade, Marex can immediately book fake “fair value” gains on instruments with highly unobservable inputs, creating the illusion of massive profitability.
Fictitious Cash Flow and Billion-Dollar Discrepancies: Marex claims strong operating cash flow (OCF), but it is a sham. Marex’s accounting includes debt issuance (senior unsecured notes)—a financing activity—in OCF. Competitors like BGC and StoneX don’t do that. Adjusting for the billions in debt reported in OCF, Marex’s OCF was negative ~$150 million in 2024 and negative ~$258 million in 2023. Worse, we discovered Marex’s SEC prospectus reports debt levels of both $2.1bn and $2.6bn for the same period. This is compounded by a history of repeated, significant financial restatements—pointing to a systemic failure of internal controls.
Lehman’s Ghosts - A Legacy of Deception: The questionable accounting surrounding Marex's debt—including its use to create fictitious cash flow and over $550 million in reporting discrepancies—is especially alarming given the leadership's history. According to bankruptcy filings, current CEO Ian Lowitt was embroiled in Lehman Brothers’ infamous “Repo 105” scandal—an accounting scheme used to temporarily hide leverage in the lead-up to the firm’s collapse. Paolo Tonucci, Lehman’s then-treasurer and now head of Marex Capital Markets, allegedly played a role in concealing the scheme from analysts at the time.
Last updated: 2026-03-07 by automated standardization process